Trial Profile
Pilot phase II trial of bevacizumab in combination with hormonal and radiotherapy in patients with high-risk prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Bicalutamide; Goserelin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 25 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.